A study of agreement between the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions

Indian Journal of Pharmacology

Volumn 46, Issue 1, 2014, Pages 117-120

  Belhekar, Mahesh N ^a   Taur, Santosh R ^a   Munshi, Renuka P ^a  

^a BYL NAIR CHARITABLE HOSPITAL   (India)

Author keywords

Agreement between scales; Causality assessment; Naranjo algorithm; WHO UMC criteria

Indexed keywords

ADULT; ADVERSE DRUG REACTION; AGED; ALGORITHM; ARTICLE; EPIDEMIOLOGICAL MONITORING; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICIAN; TERTIARY CARE CENTER; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

AGREEMENT BETWEEN SCALES; CAUSALITY ASSESSMENT; NARANJO ALGORITHM; WHO-UMC CRITERIA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; CAUSALITY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; MALE; WORLD HEALTH ORGANIZATION;

EID: 84893216117     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.125192     Document Type: Article

References (22)

1. Medicines: Safety of medicines - adverse drug reactions definition. Fact sheet No. 273. Updated October 2008 WHO Available from: www.who.int/mediacentre/ factsheets/fs293 [Last accessed on 2013 Jan 28].
2. Ditto AM. Drug allergy. In: Grammer LC, Greenberger PA, editors. Patterson's Allergic Diseases. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2002. p. 295.
3. The use of the WHO-UMC system for standardized case causality assessment. World Health Organization (WHO) - Uppsala Monitoring Centre. Available from: http://www.who-umc.org/Graphics/24734.pdf [Last accessed on 2013 Apr 10].
4. Macedo AF, Marques FB, Ribeiro CF, Teixeira F. Causality assessment of adverse drug reactions: Comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel. Pharmacoepidemiol Drug Saf 2005;14: 885-90.
5. Arimone Y, Begaud B, Miremont-Salame G, Fourrier-Reglat A, Moore N, Molimard M, et al. Agreement of expert judgment in causality assessment of adverse drug reactions. Eur J Clin Pharmacol 2005;61: 169-73.
6. Agbabiaka TB, Savovic J, Ernst E. Methods for causality assessment of adverse drug reactions: A systematic review. Drug Saf 2008;31: 21-37.
7. Turner WM. The Food and Drug Administration algorithm. Special workshop- regulatory. Drug Inf J 1984;18: 259-66.
8. Srinivasan R, Ramya G. Adverse drug reaction - Causality assessment. Int J Res Pharm Chem 2011;1: 606-12.
9. Naranjo CA, Busto U, Sellars EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30: 239-45.
10. Cantor AB. Sample-size calculations for Cohen's Kappa. Psychological Methods 1996;1: 150-3.
11. Arimone Y, Miremont-Salamé G, Haramburu F, Molimard M, Moore N, Fourrier- Réglat A, et al. Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions. Br J Clin Pharmacol 2007;64: 482-8.
12. Blanc S, Leuenberger P, Berger JP, Brooke EM, Schelling JL. Judgements of trained observers on adverse drug reactions. Clin Pharmacol Ther 1979;25: 493-8.
13. Karsh FE, Smith CL, Kerzner B, Mazzullo JM, Weintraub M, Lasanga L. Adverse drug reactions-a matter of opinion. Clin Pharmacol Ther 1976;19: 489-92.
14. Rehan HS, Chopra D, Kakkar AK. Causality assessment of spontaneously reported adverse drug events: Comparison of WHO-UMC criteria and Naranjo probability scale. Int J Risk Saf Med 2007;19: 223-7.
15. Son MK, Lee YW, Jung HY, Yi SW, Lee KH, Kim SU, et al. Comparison of the naranjo and WHO-uppsala monitoring centre criteria for causality assessment of adverse drug reactions. Korean J Med 2008;74: 181-7.
16. Lei HS, Rahman AF, Haq AS. Adverse drug reaction reports in Malaysia: Comparison of causality assessments. Malays J Pharm Sci 2007;5: 7-17.
17. Garcia-Cortes M, Lucena MI, Pachkoria K, Borraz Y, Hidalgo R, Andrade RJ, et al., Spanish Group for the Study of Drug-induced Liver Disease (grupo de Estudio para las Hepatopatías Asociadas a Medicamentos, Geham). Evaluation of naranjo adverse drug reactions probability Scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 2008;27: 780-9.
18. Pere JC, Begaud B, Haramburu F, Albin H. Computerized comparison of six adverse drug reaction assessment procedures. Clin Pharmacol Ther 1986;40: 451-61.
19. Meyboom RH, Hekster YA, Egberts AC, Gribnau FW, Edwards IR. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Safety 1997;17: 374-89.
20. Kane-Gill SL, Visweswaran S, Saul MI, Wong AK, Penrod LE, Handler SM Computerized detection of adverse drug reactions in the medical intensive care unit. Int J Med Inform 2011;80: 570-8.
21. Oderda GM, Said Q, Evans RS, Stoddard GJ, Lloyd J, Jackson K, et al. Opioidrelated adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother 2007;41: 400-7.
22. Kane-Gill SL, Forsberg EA, Verrico MM, Handler SM. Comparison of three pharmacovigilance algorithms in the ICU Setting: A retrospective and prospective evaluation of ADRs. Drug Safety 2012;35: 645-53.